Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort…
High risk of bleeding is immediately evident with TT after myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation and TT should only be prescribed after thorough bleeding risk assessment of patients. Expand
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
- S. Kristensen, Rasmus Rørth, +6 authors J. McMurray
- The lancet. Diabetes & endocrinology
- 1 October 2019
Overall, GLP-1 receptor agonist treatment reduced MACE by 12% and there was no increase in risk of severe hypoglycaemia, pancreatitis, or pancreatic cancer. Expand
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
- M. Lamberts, G. Gislason, +8 authors M. L. Hansen
- Journal of the American College of Cardiology
- 10 September 2013
In real-life AF patients with indication for multiple antithrombotic drugs after myocardial infarction or percutaneous coronary intervention, OAC and clopidogrel was equal or better on both benefit and safety outcomes compared to triple therapy. Expand
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a Danish real‐world cohort study
Examination of the rate of cardiovascular disease events in patients with severe psoriasis treated with systemic anti‐inflammatory drugs found it to be high. Expand
The new pooled cohort equations risk calculator.
The development of the new ACC/AHA Pooled Cohort Equations Risk Calculator is discussed, its strengths and weaknesses, and potential implications for its routine use. Expand
Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort
- Ole Ahlehoff, L. Skov, +8 authors P. Hansen
- Journal of the European Academy of Dermatology…
- 1 June 2015
The rate of cardiovascular events, i.e. cardiovascular death, myocardial infarction and stroke, in patients with severe psoriasis treated with systemic anti‐inflammatory drugs is examined. Expand
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve…
In heart failure with preserved ejection fraction, patients with diabetes mellitus have more signs of congestion, worse quality of life, higher N-terminal pro-B-type natriuretic peptide levels, and a poorer prognosis. Expand
Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow‐up of 4.5 million Danish adults
- M. Lamberts, O. W. Nielsen, +6 authors G. Gíslason
- Journal of internal medicine
- 1 December 2014
The prognostic significance of age and continuous positive airway pressure (CPAP) therapy on cardiovascular disease in patients with sleep apnoea has not been assessed previously.
Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death – A Danish Nationwide Cohort Study
Inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke, and cardiovascular death during periods with active disease, and in remission periods, the risk of MI, stroke and cardiovasculardeath was similar to controls. Expand
Stent Thrombosis is the Primary Cause of ST-Segment Elevation Myocardial Infarction following Coronary Stent Implantation: A Five Year Follow-Up of the SORT OUT II Study
In a contemporary cohort of coronary stented patients, stent thrombosis was evident in more than 60% of subsequent STEMIs, and age, time since stent implantation, use of statins, initial PCI urgency, NSTEMI/unstable angina [subacute PCI] or stable Angina [elective PCI]), and glucose-lowering agents did not seem to influence risk of stents. Expand